×

BRIEF-Genentech says FDA approves Actemra to treat rheumatoid arthritis

Oct 12 (Reuters) - Genentech:

* FDA approves expanded indication for Actemra in rheumatoid arthritis

* Genentech-FDA expanded approved indication for actemra for treatment of

adults with moderately to severely rheumatoid arthritis

* Source text * Further company coverage

((Bangalore Newsroom; +1 646 223 8780))